Javier Martínez-Useros Selected Research

Carcinoma (Carcinomatosis)

1/2023	Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer.
12/2016	Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Martínez-Useros Research Topics

Disease

7	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 04/2014
7	Neoplasms (Cancer) 01/2023 - 04/2014
3	Alzheimer Disease (Alzheimer's Disease) 05/2023 - 02/2018
2	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2022
2	Dementia (Dementias) 05/2023 - 02/2018
2	Carcinoma (Carcinomatosis) 01/2023 - 12/2016
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 07/2016
2	Breast Neoplasms (Breast Cancer) 06/2021 - 12/2017
2	Rectal Neoplasms (Rectal Cancer) 12/2016 - 01/2016
1	Congenital Stromal Corneal Dystrophy 11/2023
1	Hereditary Corneal Dystrophies 11/2023
1	Inflammation (Inflammations) 01/2023
1	Prodromal Symptoms 11/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Carcinogenesis 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2018
1	Disease Progression 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2018
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2015
2	CateninsIBA 01/2020 - 03/2015
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2017 - 04/2014
1	Proteoglycans (Proteoglycan)IBA 11/2023
1	DecorinIBA 11/2023
1	Amyloid (Amyloid Fibrils)IBA 05/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2023
1	SRT1720IBA 01/2023
1	NAD (NADH)IBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	Sirtuin 1IBA 01/2023
1	Cell ExtractsIBA 01/2022
1	AutoantigensIBA 11/2021
1	AutoantibodiesIBA 11/2021
1	dactolisibIBA 06/2021
1	Everolimus FDA Link 06/2021
1	sapanisertibIBA 06/2021
1	MTOR InhibitorsIBA 06/2021
1	Trastuzumab (Herceptin)FDA Link 06/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	GlycogenIBA 01/2020
1	AntigensIBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020
1	CREB-Binding ProteinIBA 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2018
1	Messenger RNA (mRNA)IBA 02/2018
1	Estrogen ReceptorsIBA 12/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2017
1	Oxygen (Dioxygen)IBA 07/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2016
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 03/2015
1	Aldehyde DehydrogenaseIBA 03/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2014
1	Fluorouracil (Carac)FDA LinkGeneric 04/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2014
1	Mitogen-Activated Protein Kinase 3IBA 04/2014

Therapy/Procedure

3	Therapeutics 06/2021 - 07/2016
2	Neoadjuvant Therapy 12/2016 - 01/2016
2	Drug Therapy (Chemotherapy) 07/2016 - 04/2014
1	Chemoradiotherapy 12/2016
1	Radiotherapy 12/2016